Efficacy of Tranexamic Acid in Reducing Myomectomy-Associated Blood Loss among Patients with Uterine Myomas at Federal Teaching Hospital Abakaliki: A Randomized Control Trial
Table 4
The intraoperative and postoperative parameters of both groups.
Continuous variables
Groups
value
95% CI
SMD
value
Tranexamic acid group (A) ()
Placebo group (B) ()
Mean (SD)
Mean (SD)
Intra-op blood loss (ml)
413.6 (165.6)
713.6 (236.3)
5.66
-403.9 to -196.1
-0.212
<0.0001
Intra-op time (min)
89.0 (28.9)
120.0 (23.1)
4.54
-44.7 to -17.7
-3.301
<0.0001
Total number of fibroid nodules removed
0.71
-3.5 to 7.3
1.900
0.48
Total weight of fibroid removed
0.00
-0.4 to 0.4
0.000
1.00
Post-op blood loss (ml)
70.0 (0.0)
236.7 (61.8)
14.78
-189.3 to -144.1
-3.811
<0.0001
Post-op stay (days)
5.8 (2.1)
7.8 (1.9)
3.83
-3.1 to -1.0
-3.929
0.0003
Post operation HB (g/dl)
9.7 (1.0)
7.8 (1.5)
5.74
1.2 to 2.6
-0.122
<0.0001
Total blood loss (ml)
474.8 (141.0)
1007.1 (358.5)
7.55
-670.4 to -391.2
30.622
<0.0001
CI = confidential interval; SMD = standardized mean difference.
